INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44m ago
House PTR4m ago
SEC 13F4m ago
Robinhood Chain4m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M—
5,649 sh
Mar 30, 2026Mar 31, 2026
Page 1039 of 1737
← PrevNext →
traded Mar 30, 2026
+1d
SEC Form 4

Evidence

3
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M$49K
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

3
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

2
LJ
Locascio Dirk J.EVP, Chief Financial Officer
USFDUS Foods Holding Corp.
Gift · 10b5-1 plan
G—
85.5K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

0
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Tax withholding · 10b5-1 plan
F$132K
1,792 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M$107K
14.7K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

0
OC
O'Hara John CharlesDirector, Chief Financial Officer
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
100.0K sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 31, 2026Mar 31, 2026
traded Mar 31, 2026
+0dSEC Form 4

Evidence

0
SA
Smith Michael AlexanderChief Legal Officer
INSMINSMED Inc
Option exercise · 10b5-1 plan
M$96K
5,649 sh
Mar 30, 2026Mar 31, 2026
traded Mar 30, 2026
+1dSEC Form 4

Evidence

0
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 27, 2026Mar 31, 2026
traded Mar 27, 2026
+4dSEC Form 4

Evidence

57
SB
Schimmelpennink Evert B.Director, President, CEO and Secretary
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$251K
28.1K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

52
AA
Arima AnastasiosChief Executive Officer
IPXIPERIONX Ltd
Open-market purchase
BUY$300K
12.8K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

51
GP
George Jeffrey P.Director
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$50K
5,592 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

50
JM
Jansen John MDirector
OKLOOklo Inc.
Open-market sale
SELL$541K
10.5K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

50
CR
Chevallard Daniel R.Chief Financial Officer
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY$64K
7,500 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

49
GD
Golub DavidDirector, CEO and Chairman, 10% Owner
NONENONEGolub Capital Private Income Fund I
Open-market purchase
BUY$12.50M
511.2K sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

49
SW
Sheehan William W IIEVP, CHIEF FINANCIAL OFFICER
ROSTROSS STORES, INC.
Open-market sale
SELL$1.06M
4,883 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

44
AD
Aguirre DeAnneDirector
HTGCHercules Capital, Inc.
Open-market purchase
BUY$105K
7,317 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

43
BO
Bron OlivierCEO, Bloomingdale's
MMacy's, Inc.
Open-market sale
SELL$84K
4,712 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

43
GP
Griscom PaulSVP and Controller
MMacy's, Inc.
Open-market sale
SELL$52K
2,919 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

43
AA
Arima AnastasiosChief Executive Officer
IPXIPERIONX Ltd
Open-market purchase
BUY$1.49M
467.0K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

40
HT
Hannigan ToddDirector
IPXIPERIONX Ltd
Open-market purchase
BUY$721K
225.2K sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

36
BN
Brown Carol NDirector
SLGSL GREEN REALTY CORP
Open-market sale
SELL$182K
5,004 sh
Mar 30, 2026Mar 30, 2026
traded Mar 30, 2026
+0dSEC Form 4

Evidence

36
SM
Sever MichalCMO
NYAXNayax Ltd.
Open-market sale
SELL$1,909
35 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

36
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$6,065
110 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

36
GS
Greenberg Aaron SamuelCSO
NYAXNayax Ltd.
Open-market sale
SELL$2,945
54 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

36
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$4,356
79 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

36
TO
Tepper OrenCRO
NYAXNayax Ltd.
Open-market sale
SELL$3,143
57 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

34
TA
Taylor Mark Andrew10% Owner
CDTCDT Equity Inc.
Other acquisition or disposition
J—
9.97M sh
Feb 19, 2026Mar 30, 2026
traded Feb 19, 2026
+39dSEC Form 4

Evidence

34
BJ
Bingham JonathanGlobal Financial Controller
HSBCHSBC HOLDINGS PLC
Open-market purchase
BUY$205
13 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

34
TA
Taylor Mark Andrew10% Owner
CDTCDT Equity Inc.
Other acquisition or disposition
J—
51.42M sh
Mar 17, 2026Mar 30, 2026
traded Mar 17, 2026
+13dSEC Form 4

Evidence

34
CA
Caldwell Christopher ADirector, President and CEO
CNXCConcentrix Corp
Open-market purchase
BUY$27K
1,000 sh
Mar 26, 2026Mar 30, 2026
traded Mar 26, 2026
+4dSEC Form 4

Evidence

32
MS
Manor SagitCFO
NYAXNayax Ltd.
Open-market sale
SELL$12K
215 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

32
FL
Furman Carly LisanneCEO NAYX North America
NYAXNayax Ltd.
Open-market sale
SELL$5,945
109 sh
Mar 27, 2026Mar 30, 2026
traded Mar 27, 2026
+3dSEC Form 4

Evidence

30
TA
Taylor Mark Andrew10% Owner
CDTCDT Equity Inc.
Other acquisition or disposition
J—
46.9K sh
Feb 19, 2026Mar 30, 2026
traded Feb 19, 2026
+39dSEC Form 4

Evidence